Boston Scientific (BSX) Change in Cash (2009 - 2026)

Boston Scientific (BSX) has 18 years of Change in Cash data on file, last reported at -$504.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 260.51% year-over-year to -$504.0 million; the trailing twelve-month figure through Mar 2026 stood at $723.0 million (up 145.85% YoY), and the FY2025 full-year result was $1.5 billion, up 442.44% from the prior year.
• Change in Cash eased to -$504.0 million in Q1 2026, from $671.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $1.4 billion in Q1 2024 to a low of -$2.0 billion in Q4 2024.
• A 5-year average of -$30.9 million and a median of -$71.0 million in 2022 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash surged 6888.89% in 2022 and tumbled 2554.55% in 2024, its largest moves.
• Tracing BSX's Change in Cash over 5 years: stood at $629.0 million in 2022, then plunged by 112.24% to -$77.0 million in 2023, then plunged by 2554.55% to -$2.0 billion in 2024, then surged by 132.83% to $671.0 million in 2025, then plunged by 175.11% to -$504.0 million in 2026.
• Business Quant data shows BSX's Change in Cash at -$504.0 million in Q1 2026, $671.0 million in Q4 2025, and $735.0 million in Q3 2025.